/H113509.0%) to achieve a balanced distribu-tion of subjects across treatment arms.Within each arm, subjects were random-ized in a one-for-one ratio to either remainon their maximally effective sulfonylureadose or to decrease their sulfonylurea tothe minimum recommended dose. Asample size of 600 subjects who were ex-pected to complete treatment through week30 were estimated to provide at least 90%Exenatide and glycemic control 1084 DIABETES CARE,VOLUME 28, NUMBER 5, M AY2005